Stay informed with the latest litigation news. Explore now

IP Verse

Aav Vectors For Retinal And Cns Gene Therapy - EP3137497B2

EP3137497

GENZYME
Application Number
EP15723386A
Filing Date
May 2, 2015
Status
Patent Maintained As Amended
Jan 31, 2025
Grant Date
Mar 5, 2025
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2976359B2
EP2970843B1
EP3047013B1

Bibliography

The patent EP3137497B2 was granted to Genzyme on Mar 5, 2025 following the initial filing on May 2, 2015 under the application number EP15723386A . The current legal status of the patent is Patent Maintained As Amended.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

EUROPEAN OPPOSITIONSJan 7, 2022ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents